TMDX
TMDX
TransMedics Group, Inc.
$63.22
-$0.96 (-1.50%)
Mkt Cap: $2.18B
Home / TMDX / Financial Statements

TransMedics Group, Inc. (TMDX) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$605.49M
$605.49M ↑37.1%
$441.54M ↑82.7%
$241.62M ↑158.5%
$93.46M ↑208.8%
$30.26M
Cost of Revenue
$242.69M
$242.69M ↑35.2%
$179.46M ↑105.0%
$87.53M ↑210.5%
$28.19M ↑209.6%
$9.10M
Gross Profit
$362.81M
$362.81M ↑38.4%
$262.08M ↑70.1%
$154.09M ↑136.1%
$65.27M ↑208.5%
$21.16M
R&D Expenses
$69.06M
$69.06M ↑23.4%
$55.97M ↓11.5%
$63.27M ↑136.0%
$26.81M ↑20.2%
$22.30M
SG&A Expenses
$185.17M
$185.17M ↑9.8%
$168.62M ↑41.0%
$119.55M ↑71.0%
$69.90M ↑82.6%
$38.28M
Operating Income
$108.58M
$108.58M ↑189.6%
$37.50M ↑230.5%
-$28.73M ↑8.6%
-$31.44M ↑20.3%
-$39.43M
Interest Expense
$13.78M
$13.78M ↓4.4%
$14.41M ↑33.5%
$10.79M ↑189.6%
$3.73M ↓3.8%
$3.87M
Income Tax
-$82.77M
-$82.77M
$316,000.00 ↑119.2%
-$1.64M
$66,000.00 ↑83.3%
$36,000.00
Net Income
$190.29M
$190.29M ↑436.6%
$35.46M ↑241.7%
-$25.03M ↑30.9%
-$36.23M ↑18.1%
-$44.22M
EBITDA
$148.49M
$148.49M ↑112.3%
$69.95M
-$7.70M ↑73.4%
-$28.96M ↑24.8%
-$38.49M
EPS
4.87
4.87 ↑382.2%
1.01 ↑231.2%
-0.77 ↑37.4%
-1.23 ↑23.1%
-1.60
Shares Out (Diluted)
162.15M
40.54M ↑15.1%
35.22M ↑8.3%
32.52M ↑10.0%
29.56M ↑7.0%
27.62M